164 related articles for article (PubMed ID: 33825059)
21. CT-guided radiofrequency ablation in patients with hepatic metastases from breast cancer.
Jakobs TF; Hoffmann RT; Schrader A; Stemmler HJ; Trumm C; Lubienski A; Murthy R; Helmberger TK; Reiser MF
Cardiovasc Intervent Radiol; 2009 Jan; 32(1):38-46. PubMed ID: 18575933
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC: a five years study.
Lassandro G; Picchi SG; Bianco A; Di Costanzo G; Coppola A; Ierardi AM; Lassandro F
Med Oncol; 2020 Mar; 37(4):25. PubMed ID: 32166529
[TBL] [Abstract][Full Text] [Related]
23. Stereotactic Radiofrequency Ablation of Liver Tumors in Octogenarians.
Schullian P; Putzer D; Silva MA; Laimer G; Kolbitsch C; Bale R
Front Oncol; 2019; 9():929. PubMed ID: 31608232
[No Abstract] [Full Text] [Related]
24. Surgery for breast cancer liver metastases - factors determining results.
Treska V; Cerna M; Liska V; Treskova I; Narsanska A; Bruha J
Anticancer Res; 2014 Mar; 34(3):1281-6. PubMed ID: 24596373
[TBL] [Abstract][Full Text] [Related]
25. Feasibility and outcomes of percutaneous radiofrequency ablation for intrahepatic recurrent hepatocellular carcinoma after liver transplantation: a single-center experience.
Liu B; Huang G; Xie X; Zhao Q; Su L; Liu M; Li X; Long J; Kuang M; Xie X
Int J Hyperthermia; 2020; 37(1):1202-1209. PubMed ID: 33100042
[TBL] [Abstract][Full Text] [Related]
26. A Single-Center Retrospective Analysis of Periprocedural Variables Affecting Local Tumor Progression after Radiofrequency Ablation of Colorectal Cancer Liver Metastases.
Han K; Kim JH; Yang SG; Park SH; Choi HK; Chun SY; Kim PN; Park J; Lee M
Radiology; 2021 Jan; 298(1):212-218. PubMed ID: 33170105
[TBL] [Abstract][Full Text] [Related]
27. Quality of life analysis after stereotactic radiofrequency ablation of liver tumors.
Schullian P; Gertl A; Laimer G; Putzer D; Siebert U; Levy E; Bale R
Sci Rep; 2020 Jul; 10(1):12809. PubMed ID: 32732877
[TBL] [Abstract][Full Text] [Related]
28. Stereotactic radiofrequency ablation of primary liver tumors in the caudate lobe.
Schullian P; Laimer G; Putzer D; Effenberger M; Bale R
HPB (Oxford); 2020 Mar; 22(3):470-478. PubMed ID: 31591012
[TBL] [Abstract][Full Text] [Related]
29. Percutaneous ultrasound-guided radiofrequency ablation for patients with liver metastases from gastrointestinal stromal tumors.
Liu L; Wang B; Zhang ZY; Wang S; Wu H; Wang H; Wu W; Yan K; Yang W
Int J Hyperthermia; 2024; 41(1):2292950. PubMed ID: 38159558
[TBL] [Abstract][Full Text] [Related]
30. Treatment of pulmonary colorectal metastases by radiofrequency ablation.
Petre EN; Jia X; Thornton RH; Sofocleous CT; Alago W; Kemeny NE; Solomon SB
Clin Colorectal Cancer; 2013 Mar; 12(1):37-44. PubMed ID: 23026111
[TBL] [Abstract][Full Text] [Related]
31. CT-guided percutaneous radiofrequency ablation for lung metastases from colorectal cancer.
Hiyoshi Y; Miyamoto Y; Kiyozumi Y; Sawayama H; Eto K; Nagai Y; Iwatsuki M; Iwagami S; Baba Y; Yoshida N; Kawanaka K; Yamashita Y; Baba H
Int J Clin Oncol; 2019 Mar; 24(3):288-295. PubMed ID: 30328530
[TBL] [Abstract][Full Text] [Related]
32. Feasibility, safety, and long-term efficacy of stereotactic radiofrequency ablation for tumors adjacent to the diaphragm in the hepatic dome: a case-control study.
Schullian P; Putzer D; Laimer G; Levy E; Bale R
Eur Radiol; 2020 Feb; 30(2):950-960. PubMed ID: 31489472
[TBL] [Abstract][Full Text] [Related]
33. Does the Site of the Primary Affect Outcomes When Ablating Colorectal Liver Metastases with Radiofrequency Ablation?
Gu Y; Huang Z; Gu H; Gao F; Zhang T; Huang S; Huang J
Cardiovasc Intervent Radiol; 2018 Jun; 41(6):912-919. PubMed ID: 29582125
[TBL] [Abstract][Full Text] [Related]
34. Radiofrequency ablation vs. surgery for perivascular hepatocellular carcinoma: Propensity score analyses of long-term outcomes.
Lee S; Kang TW; Cha DI; Song KD; Lee MW; Rhim H; Lim HK; Sinn DH; Kim JM; Kim K
J Hepatol; 2018 Jul; 69(1):70-78. PubMed ID: 29524532
[TBL] [Abstract][Full Text] [Related]
35. Long-term outcome of percutaneous radiofrequency ablation in recurrent hepatocellular carcinoma after liver transplantation.
Yang W; Wu H; Zhang ZY; Lee JC; Wang S; Wang YJ; Wu W; Chen MH; Yan K
Int J Hyperthermia; 2018 Feb; 34(1):68-76. PubMed ID: 28540818
[TBL] [Abstract][Full Text] [Related]
36. Percutaneous Radiofrequency Ablation for Metachronous Hepatic Metastases after Curative Resection of Pancreatic Adenocarcinoma.
Lee SJ; Kim JH; Kim SY; Won HJ; Shin YM; Kim PN
Korean J Radiol; 2020 Mar; 21(3):316-324. PubMed ID: 32090524
[TBL] [Abstract][Full Text] [Related]
37. Locally ablative treatment of breast cancer liver metastases: identification of factors influencing survival (the Mammary Cancer Microtherapy and Interventional Approaches (MAMMA MIA) study).
Seidensticker M; Garlipp B; Scholz S; Mohnike K; Popp F; Steffen I; Seidensticker R; Stübs P; Pech M; PowerskI M; Hass P; Costa SD; Amthauer H; Bruns C; Ricke J
BMC Cancer; 2015 Jul; 15():517. PubMed ID: 26169362
[TBL] [Abstract][Full Text] [Related]
38. Long-term Observation of CT-guided Radiofrequency Ablation of Lung Neoplasm in 476 Consecutive Patients by a Thoracic Surgical Service: A Single-institutional Experience.
Huang BY; Zhou JJ; Yu ZQ; Song XY; Lin Y; Li XM; Li L
Acad Radiol; 2017 Dec; 24(12):1517-1525. PubMed ID: 28888381
[TBL] [Abstract][Full Text] [Related]
39. Value of MRI/CT Image Fusion for Targeting "invisible" Lesions in Stereotactic Microwave Ablation (SMWA) of Malignant Liver Lesions: A Retrospective Analysis.
Cathomas M; Mertineit N; Kim-Fuchs C; Lachenmayer A; Maurer MH
Cardiovasc Intervent Radiol; 2020 Oct; 43(10):1505-1514. PubMed ID: 32642989
[TBL] [Abstract][Full Text] [Related]
40. Thermal ablation of CT 'invisible' liver tumors using MRI fusion: a case control study.
Schullian P; Johnston E; Laimer G; Putzer D; Eberle G; Westerlund P; Henninger B; Bale R
Int J Hyperthermia; 2020; 37(1):564-572. PubMed ID: 32484004
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
